These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8724043

  • 1. Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma.
    Uthayakumar S, Bower M, Money-Kyrle J, Muyshondt C, Youle M, Hannon F, Phillips R, Gazzard BG, Boag F.
    AIDS; 1996 May; 10(5):515-9. PubMed ID: 8724043
    [Abstract] [Full Text] [Related]

  • 2. Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma.
    White RM.
    AIDS; 1997 Sep; 11(11):1412-3. PubMed ID: 9302461
    [No Abstract] [Full Text] [Related]

  • 3. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
    Girard PM, Bouchaud O, Goetschel A, Mukwaya G, Eestermans G, Ross M, Rozenbaum W, Saimot AG.
    AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866
    [Abstract] [Full Text] [Related]

  • 4. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.
    Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS.
    J Clin Oncol; 1998 Oct; 16(10):3369-74. PubMed ID: 9779714
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [Abstract] [Full Text] [Related]

  • 15. Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment.
    Fléchon A, Lombard-Bohas C, Boulez J, Blay JY, Scoazec JY.
    Ann Oncol; 2001 Feb; 12(2):275-6. PubMed ID: 11300338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
    Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM.
    J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.